Header Logo

Connection

MICHAEL BRAUN to ras Proteins

Back to Details
This is a "connection" page, showing publications MICHAEL BRAUN has written about ras Proteins.
MICHAEL BRAUN
Connection Strength
0.023
ras Proteins
  1. A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer. Eur J Cancer. 2014 Dec; 50(18):3136-44.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.